Related Experiment Videos
Signal transduction by inflammatory cytokines
1Section of Molecular Rheumatology, Clinical Research Centre, Harrow, UK.
Clinical and Experimental Rheumatology
|May 1, 1993
Summary
This review covers how inflammatory cytokines like interleukin-1 (IL-1) and interleukin-6 (IL-6), plus tumor necrosis factor-alpha (TNF-α), activate genes. Emerging receptor and transcription factor use suggests new therapeutic strategies.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Inflammatory cytokines play crucial roles in cellular processes.
- Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α) are key mediators of inflammation.
- Understanding their gene activation pathways is vital for disease research.
Purpose of the Study:
- To review the mechanisms of gene activation by IL-1, IL-6, and TNF-α.
- To identify common pathways involving receptors and transcription factors.
- To explore potential therapeutic targets based on these mechanisms.
Main Methods:
- Literature review of studies on cytokine signaling.
- Analysis of commonalities in receptor usage.
- Identification of frequently involved transcription factors.
Main Results:
- Common receptors and transcription factors are increasingly recognized in IL-1, IL-6, and TNF-α signaling.
- These shared components provide a unified view of cytokine-mediated gene regulation.
- Specific examples of activated genes and their regulatory elements are discussed.
Conclusions:
- The shared molecular machinery for cytokine-induced gene activation offers significant therapeutic potential.
- Targeting common receptors or transcription factors may lead to novel anti-inflammatory treatments.
- Further research into these pathways can refine therapeutic strategies for inflammatory diseases.